Glofitamab with gemcitabine and oxaliplatin for treating relapsed or refractory diffuse B-cell lymphoma [ID6202]

Draft guidance: 1

Draft guidance (downloadable version) (PDF 252 KB)

Draft guidance (online commenting)

Committee papers (PDF 5.42 MB)

Public committee slides (PDF 624 KB)

Final scope (PDF 177 KB)

Final stakeholder list (PDF 137 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 134 KB)

Draft scope post referral (PDF 242 KB)